Bimatoprost
Bimatoprost is an approved active ingredient.
Chemical compound
What it is used for
- Glaucoma
- Hypotrichosis
- Open-angle glaucoma
- Ocular hypertension
DURYSTA ® (bimatoprost intracameral implant) is indicated for the reduction of intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension (OHT).
Reduction of elevated intraocular pressure in chronic open-angle glaucoma and ocular hypertension (as monotherapy or as adjunctive therapy to beta-blockers).
How it works
- Prostanoid FP receptor agonist
Common side effects
The following clinically significant adverse reactions are described elsewhere in labeling: Implant migration Hypersensitivity Corneal adverse reactions Macular edema Intraocular inflammation Pigmentation Endophthalmitis In controlled studies, the most common ocular adverse reaction reported by 27% of patients was…
Who should not take it
Ocular or periocular infections Corneal endothelial cell dystrophy Prior corneal transplantation Absent or ruptured posterior lens capsule Hypersensitivity 4.1 Ocular or Periocular Infections DURYSTA is contraindicated in patients with active or suspected…
Pregnancy and breastfeeding
There are no adequate and well-controlled studies of DURYSTA (bimatoprost intracameral implant) administration in pregnant women to inform a drug associated risk.
Brand names
United States
Durysta · Latisse · Lumigan · Zolymbus
European Union
Lumigan
Canada
Ag-Bimatoprost RC · Apo-Bimatoprost · Apo-Bimatoprost RC · Bimatoprost RC · Jamp Bimatoprost · Jamp Bimatoprost Solution RC · Latisse · Lumigan RC · Pro-Bimatoprost RC · Vistitan · Zimed PF · Zolymbus
Approval status
- US Food and Drug Administration
- prescription · since 2001
- European Medicines Agency
- authorised · since 2002
- Health Canada
- prescription · marketed
- First approval anywhere
- 2001
Codes
- ATC
- S01EE03
- RxNorm CUI
- 283810
- ChEMBL
- CHEMBL1200963
- PubChem CID
- 5311027
- UNII
- QXS94885MZ
- Wikidata
- Q2393348
Frequently asked questions
What is Bimatoprost used for?
Bimatoprost is used for: Glaucoma, Hypotrichosis, Open-angle glaucoma, and Ocular hypertension.
What are the brand names of Bimatoprost?
Brand names of Bimatoprost include Durysta, Latisse, Lumigan, Zolymbus, Ag-Bimatoprost RC, Apo-Bimatoprost, Apo-Bimatoprost RC, and Bimatoprost RC.
Medicines in the same class
Sources and licences
- ChEMBL (CC BY-SA 3.0)
- Wikidata (CC0 1.0)
- openFDA / DailyMed (public domain)
- European Medicines Agency (reuse with acknowledgement)
- Health Canada Drug Product Database (Open Government Licence – Canada)